ω-3 짿�방산과 심혈관계 질환(CVD)의 관계

· 신지예, “국민건강영양조사(20082010)를 이용한 성인의 심혈관 질환과 식이패턴, 혈중 중금속 농도, 생선섭취왿�의 관련성”, 이화여자대학껓 댿�학원 석사논��, 2012
· Emken EA, Adlof RO, Gulley RM. “Dietary linoleic acid influences desaturation and acylation of deuteriumlabeled linoleic and linolenic acids in young adult males”. Biochim Biophys Acta 1994;1213(3):27788.
· Burdge GC, Finnegan YE, Minihane AM, Williams CM, Wootton SA. Effect of altered dietary n3 fatty acid intake upon plasma lipid fatty acid composition,conversion of [13C]alphalinolenic acid to longerchain fatty acids and partitioning towards betaoxidation in older men. Br J Nutr 2003;90(2):31121.
· 정보영, 오메가3 짿�방산의 식품중 분포왿� 생리학적 기능, 한국작물학회지, 1997
· Burdge G, Alphalonolenic acid metabolism in men and women: nutritional and biological inmlications, Curr Opin Clin Nutr Metab Care, 2004
· Mazaffarian DM, Ascherio A, Hu FB, Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men, Circulation, 2005
· 문태영, 서재수, 송명재, 오메가3 짿�방산의 심혈관계 보호기능, 보건과학연구소보, 2008
· Chen I. S., S. Subramaniam. M. Cassidy, A. D. Sheppard and G. V. Vahouny, J. Nutr, 1985
· 이혜란, “중년여성에서 신체활동과 비만의 상호작용이 심혈관 질환 위험에 미치는 영향”,아주대학껓,2011
· Trevor A. Mori, “Dietary n3 PUFA and CVD: a review of the evidence”, Proceedings of the Nutrition Society, Page 1 of 8
· Thies F, Garry JMC, Yaqoob P et al. (2003) Association of n3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361, 477–485.
· Harris WS (1996) “n3 Fatty acids and lipoproteins: comparison of results from human and animal studies”. Lipids 31, 243–252.
· Harris WS (1997) “n3 Fatty acids and serum lipoproteins:human studies”. Am J Clin Nutr 65, Suppl. 5, 1645S–1654S.
· 박용순, “심혈관계 질환의 위험지표로서 Omega3 Index에 대한 올바른 이해 및 한국인에의 적용”, 대한비만학회지: 제 19 권 제 1 호 2010, pp. 724~727
· Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, et al. “Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size,glucose, and insulin in mildly hyperlipidemic men”. Am J Clin Nutr 2000;71(5):108594.
· von Schacky C. “A review of omega3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels”. Vasc Health Risk Manag 2006;2(3):25162.
· 박선혜, 심혈관계 질환에 오메가3 짿�방산이 미치는 영향= Effect of n3 fatty acid on cardiovascular disease, 한양대학껓 댿�학원 석사논��, 2009
· Din JN, Newby DE, Flapan AD. “Omega 3 fatty acids and cardiovascular diseasefishing for a natural treatment”. BMJ 2004;328(7430):305.
· Harris WS, Park YS, Isley WL. “Cardiovascular disease and longchain omega3 fatty acids”. Curr Opin Lipidol 2003;14(1):914.
· Park YS, Harris WS. “EPA, but not DHA, decreases mean platelet volume in normal subjects”. Lipids 2002;37(10):9416.
· Trevor A. Mori, “Dietary n3 PUFA and CVD: a review of the evidence”, Proceedings of the Nutrition Society, Page 1 of 8
· Siess, W., P. Roth, B. Scherer, I. Kurzmann, B. Bhlig and P. C. Weber(1980), Lancet. I, 441
· O'Keefe JH Jr, Abuisssa H, Sastre A, Sterinhaus DM,Harris WS. “Effects of omeg3 fatty acids on resting heart rate, heart rat recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fraction”. Am J Cardiol 2006;97(8):112730.
· 정세원, 김지연, 백주은, 김주희, 곽진숙, 권오란, 건강기능식품의 기능성을 중심으로 한 오메가3 짿�방산 함유유지의 혈행개선 효과에 대한 체계적 고찰, Journal of Nutrition and Health, 2013;46(3) 226~238
· Ricky Turgeon, Fred janke, Michael R. Kolber, Omega3 for patients with cardiovascular disease, Can Fam Physician, 2012; 58(11):1225 곽상미, 오메가 3 짿�방산 보충제의 심혈관계 질환 이차발생 예방효과에 관한 메타분석, 충남대학껓 댿�학원 석사논��, 2012
· Atul Singhal, Julie Lanigan, Clare Storry, Sarah Low, Toni Birbara, Alan Lucas and John Deanfield , Docosahexaenoic Acid Supplementation, Vascular Function and Risk Factors for Cardiovascular Disease: A Randomized Controlled Trial in Young Adults, J Am Heart Assoc. 2013; p7